Product Discontinuation Notice

Dear Customer,

after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.

While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.

Don’t Miss Out on Our MEDICA Talks

QIAGEN Lake Constance has developed an open IVD-compliant lateral flow reader platform that is capable of reading almost any lateral flow test format in a very accurate way. Discover more about our aLF platform by attending our MEDICA talks at Hall 03, Booth C80, the event stage on the joint stand of the State of North Rhine-Westphalia (click here for more program details):

Monday, November 13, at 1pm: Increased diagnostic competence in preventive medicine through digital diagnostics of saliva (aMMP8) and its quantitative evaluation using aLF Reader system.

Tuesday, November 14, at 1pm: Manufacturer’s insight – benefits of an open platform for the detection of rapid tests in the in-vitro diagnostics field.

You are also cordially invited to join the reception at our booth (Hall 03, Booth E84) which will take place straight after the Tuesday talk.

We look forward to meeting you at MEDICA in two weeks!